APA (7th ed.) Citation

Bergmann, L., Ahrens, M., Albiges, L., Gross Goupil, M., Boleti, E., Gravis, G., . . . Haanen, J. (2024). LBA75 Prospective randomised phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer: Results of the SUNNIFORECAST trial. Annals of Oncology, 35, S1263. https://doi.org/10.1016/j.annonc.2024.08.2318

Chicago Style (17th ed.) Citation

Bergmann, L., et al. "LBA75 Prospective Randomised Phase-II Trial of Ipilimumab/nivolumab Versus Standard of Care in Non-clear Cell Renal Cell Cancer: Results of the SUNNIFORECAST Trial." Annals of Oncology 35 (2024): S1263. https://doi.org/10.1016/j.annonc.2024.08.2318.

MLA (9th ed.) Citation

Bergmann, L., et al. "LBA75 Prospective Randomised Phase-II Trial of Ipilimumab/nivolumab Versus Standard of Care in Non-clear Cell Renal Cell Cancer: Results of the SUNNIFORECAST Trial." Annals of Oncology, vol. 35, 2024, p. S1263, https://doi.org/10.1016/j.annonc.2024.08.2318.